Treatment of cell proliferative disorders with chlorotoxin

Details for Australian Patent Application No. 2003237347 (hide)

International Classifications

Event Publications

11 September 2003 Complete Application Filed

Priority application(s): 60/384,171 31.05.02 US; 60/406,033 27.08.02 US

12 February 2004 Application Open to Public Inspection

Published as AU-B-2003237347

17 February 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

28 April 2005 Section 223 Application Allowed

TRANSMOLECULAR INC. The time in which to enter the National Phase has been extended to 31 Jan 2005. Address for service in Australia - Allens Arthur Robinson The Chifley Tower 2 Chifley Square SYDNEY NSW 2000

23 July 2009 Application Accepted

Published as AU-B-2003237347

19 November 2009 Standard Patent Sealed

6 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.